Medicated Feed Additives Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Antibiotics, Vitamins, Antioxidants, Amino Acids, Prebiotics, Probiotics, Enzymes, Other), By Mixture Type (Supplements, Concentrates, Premixes, Base Mixes), By Animal Type (Ruminants, Swine, Poultry, Aquaculture, Others), By Region, Competition, 2020-2030F

Market Overview

The Global Medicated Feed Additives Market, valued at USD 11.98 Billion in 2024, is projected to experience a CAGR of 5.58% to reach USD 16.59 Billion by 2030. Medicated feed additives are specialized compounds integrated into animal feed to prevent, control, or treat diseases, enhance nutrient utilization, and optimize growth and productivity in livestock. The global market for these products is primarily supported by the increasing worldwide demand for animal protein, which necessitates improved livestock health and feed efficiency within intensive farming operations. Furthermore, the rising incidence of animal diseases and an escalating focus on effective disease prevention strategies significantly contribute to market expansion.

According to the European Feed Manufacturers' Federation (FEFAC), in 2023, the EU-27 compound feed industry incorporated 4.8 million tons of various additives, including minerals and vitamins, within its total production of 145 million tons of feed. Despite this demand, a significant challenge impeding market growth is the increasingly stringent global regulatory landscape governing the use of certain feed additives, particularly antibiotics, driven by heightened concerns regarding antimicrobial resistance.

Key Market Drivers

The rising global demand for animal protein is a primary accelerator for the medicated feed additives market. As populations grow and disposable incomes increase in developing economies, the consumption of meat, dairy, and eggs escalates, compelling livestock producers to intensify operations and enhance feed efficiency. This necessitates the widespread adoption of additives that promote animal growth, optimize nutrient absorption, and maintain herd health under concentrated farming conditions. For instance, according to the Food and Agriculture Organization (FAO), in 2024, global meat production is forecast to reach 373 million tonnes, reflecting a 1.4 percent increase from 2023, highlighting the continuous pressure on livestock systems to boost output. Medicated feed additives become indispensable in ensuring animal productivity and preventing economic losses in this high-demand environment.

Concurrently, the increasing prevalence of animal diseases represents another critical determinant driving market expansion. Outbreaks of highly contagious diseases devastate livestock populations, leading to significant economic losses for farmers and potential threats to food security. To mitigate these risks, there is a heightened reliance on medicated feed to prevent and control infections, ensuring animal welfare and safeguarding food chains. A notable example is African Swine Fever, where, according to Livetec Systems, in May 2024, "African swine fever continues to plague the global pig industry", Europe recorded 12,121 outbreaks in 2023, nearly double the cases reported in 2022, underscoring the persistent disease burden requiring robust prophylactic and therapeutic solutions. The broader animal health sector, of which feed additives are a component, continues to show robust growth; according to Zoetis Inc. , in February 2025, the company reported full year 2024 revenue of $9.3 billion, an 8% increase compared with full year 2023, demonstrating strong performance in a market impacted by ongoing animal health concerns.

Download Free Sample Report

Key Market Challenges

The increasingly stringent global regulatory landscape presents a significant challenge to the growth of the medicated feed additives market. Heightened concerns regarding antimicrobial resistance have led to stricter controls on the use of certain feed additives, particularly antibiotics, across various regions. These regulatory pressures compel feed manufacturers and livestock producers to seek alternatives, thereby limiting the traditional market for antibiotic-based additives.

This restrictive environment directly impedes market expansion by reducing the approved scope and volume of antibiotic inclusion in animal feed. For instance, according to the World Organisation for Animal Health (WOAH), global antimicrobial use in animals declined by 13% over three years, as reported in September 2023. This substantial reduction indicates a direct consequence of policies aimed at mitigating antimicrobial resistance, which in turn diminishes the market potential for feed additives containing these specific compounds. The shift towards non-antibiotic growth promoters and disease prevention strategies further redirects market demand away from conventional medicated feed additive solutions.

Key Market Trends

The medicated feed additives market is notably shifting towards antibiotic alternatives and non-medicinal solutions, driven by antimicrobial resistance concerns and stricter regulations. This trend prioritizes developing and adopting products like probiotics and phytogenics to sustain animal health. The European Feed Manufacturers' Federation (FEFAC) reported a 40% decrease in antibiotic premixture sales in the EU-27 in 2022 compared to 2021, underscoring this redirection. These innovations foster sustained animal productivity through prophylactic nutrition. In April 2025, Evonik Vland Biotech introduced Ecobiol®, a poultry probiotic in mainland China, the region's first registered feed-grade Bacillus subtilis. This exemplifies effective, non-antibiotic health management.

Increased adoption of precision livestock farming for optimized additive use significantly transforms the global medicated feed additives market. This integrates advanced technologies and data analytics to tailor feed formulations and additive dosages, maximizing efficiency and minimizing waste. The European Feed Manufacturers' Federation (FEFAC) in its Feed & Food Report 2024 noted the compound feed industry's increasing reliance on technological advancements for efficiency and sustainability, enabling tailored feed formulations. This provides precise nutritional support, enhancing animal health and productivity sustainably. Demonstrating this, DSM-Firmenich inaugurated a new Brazilian facility in October 2024, emphasizing FarmTell digital farm management software, which was monitoring over 5 million animals across 6,000 farms. This integration improves feed additive efficacy and resource utilization.

Segmental Insights

The Supplements segment is experiencing rapid growth within the Global Medicated Feed Additives Market, driven by a confluence of factors emphasizing animal health and sustainable livestock production. This expansion is largely attributed to increasing global demand for high-quality animal protein, which necessitates efficient animal farming practices to enhance productivity and feed conversion. Furthermore, growing awareness among consumers and regulators, such as the U. S. Food and Drug Administration and European Union bodies, regarding antibiotic resistance, has prompted a shift towards alternative solutions like probiotics, prebiotics, and essential vitamins and minerals. These nutritional supplements contribute to improved animal welfare, reduced disease incidence, and enhanced meat quality, offering concentrated nutrition and therapeutic potential in animal diets.

Regional Insights

Asia Pacific stands as the leading region in the Global Medicated Feed Additives Market due to its expansive livestock population and the escalating demand for animal protein driven by rising incomes and urbanization. This necessitates industrial-scale farming practices, increasing the reliance on medicated feed additives for disease prevention and enhanced productivity. Governments across the region, including through bodies such as China's Ministry of Agriculture and Rural Affairs and India's Food Safety and Standards Authority, are also strengthening regulatory frameworks to ensure feed safety and manage antimicrobial resistance, further driving the adoption of specialized feed solutions.

Recent Developments

• In March 2025, Cargill introduced a new portfolio of brands for its Micronutrition and Health Solutions (MHS) business at VIV Asia 2025 in Bangkok, Thailand. These innovations, stemming from extensive scientific research, are designed to optimize animal production and foster long-term sustainability within the global medicated feed additives market. Key solutions presented included Biostrong™ products, intended to enhance digestive health and growth in poultry, and advanced Notox™ solutions for effective mycotoxin management. Cargill also showcased digital innovations such as Galleon™, an AI-powered platform for analyzing the gut microbiome of livestock, and Reveal™ Layers, a Near-Infrared (NIR) technology for non-invasive poultry body fat measurement, underscoring its commitment to data-driven animal health.

• In September 2024, Novus International, Inc. and Ginkgo Bioworks formed a strategic partnership focused on the development of advanced feed additives for the animal agriculture industry. This collaboration utilizes Ginkgo Enzyme Services to create more efficient enzymes that can be produced cost-effectively. The initiative addresses contemporary challenges within the agricultural sector, such as escalating feed costs and tightening margins. By introducing innovative technologies, the partnership aims to improve the sustainability and efficiency of animal production systems. These advancements are designed to optimize the health and performance of livestock, including chickens, pigs, and cows, thereby assisting producers in delivering nutritious and affordable animal products.

• In May 2024, Elanco Animal Health Incorporated announced that the U.S. Food and Drug Administration (FDA) successfully completed its comprehensive review of Bovaer®, a pioneering feed ingredient developed to reduce methane emissions in lactating dairy cattle. The FDA confirmed that Bovaer met all established safety and efficacy standards, representing a notable advancement in sustainable animal agriculture. This regulatory approval cleared the path for Elanco to introduce the product to the U.S. market, with commercial availability projected for the third quarter of 2024. Bovaer functions by inhibiting an enzyme in the bovine rumen that contributes to methane production, potentially reducing emissions by approximately 30% per cow daily. Elanco also broadened its distribution agreement with dsm-firmenich for Bovaer across North America.

• In April 2024, Zoetis Inc. entered into a definitive agreement to divest its medicated feed additive (MFA) product portfolio, including certain water-soluble products and associated assets, to Phibro Animal Health Corporation. This transaction, valued at $350 million, was anticipated to be finalized in the second half of 2024. The strategic divestment allowed Zoetis to redirect its livestock investments towards other solutions such as vaccine and biologic programs. For Phibro Animal Health, this acquisition significantly expanded and diversified its global offerings in medicated feed additives for cattle, swine, and poultry, aiming to enhance the company’s profitability and earnings margins. The deal encompassed over 37 product lines and six manufacturing facilities located across the U.S., Italy, and China.

Key Market Players

• Phibro Animal Health Corporation
• Cargill, Incorporated
• Archer Daniels Midland Company
• CHS Inc.
• Purina Animal Nutrition LLC. (Land O' Lakes)
• Adisseo France SAS
• Kemin Industries Inc.
• Alltech Inc.

Report Scope:

In this report, the Global Medicated Feed Additives Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Medicated Feed Additives Market, By Type:

o   Antibiotics

o   Vitamins

o   Antioxidants

o   Amino Acids

o   Prebiotics

o   Probiotics

o   Enzymes

o   Other

• Medicated Feed Additives Market, By Mixture Type:

o   Supplements

o   Concentrates

o   Premixes

o   Base Mixes

• Medicated Feed Additives Market, By Animal Type:

o   Ruminants

o   Swine

o   Poultry

o   Aquaculture

o   Others

• Medicated Feed Additives Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Medicated Feed Additives Market.

Available Customizations:

Global Medicated Feed Additives Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Medicated Feed Additives Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]